Variant report

Variant	esv1832858
Chromosome Location	chr19:56256126-56286617
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:28)
CpG islands
(count:306)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:28 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr19:56268023-56268280	A549	lung:	n/a	chr19:56268130-56268143
2	CEBPB	chr19:56267971-56268186	K562	blood:	n/a	chr19:56268130-56268143
3	CEBPB	chr19:56268125-56268161	Hela-S3	cervix:	n/a	chr19:56268130-56268143
4	CEBPB	chr19:56277973-56278182	K562	blood:	n/a	chr19:56278128-56278141
5	CEBPB	chr19:56258745-56258858	HepG2	liver:	n/a	chr19:56258809-56258820
6	CTCF	chr19:56270569-56270612	GM13976	blood:	n/a	n/a
7	CTCF	chr19:56258305-56258414	MCF-7	breast:	n/a	n/a
8	CTCF	chr19:56258237-56258238	GM19239	blood:	n/a	n/a
9	CTCF	chr19:56258240-56258344	GM19239	blood:	n/a	n/a
10	CTCF	chr19:56264236-56264269	Lung_OC	lung:	n/a	n/a
11	CTCF	chr19:56258247-56258265	MCF-7	breast:	n/a	n/a
12	CTCF	chr19:56277860-56278010	HAc	cerebellar:	n/a	n/a
13	CTCF	chr19:56283229-56283313	GM10266	blood:	n/a	n/a
14	CTCF	chr19:56282862-56282960	GM13976	blood:	n/a	n/a
15	CTCF	chr19:56283320-56283323	GM10266	blood:	n/a	n/a
16	E2F4	chr19:56270326-56270356	MCF10A-Er-Src	breast:	n/a	n/a
17	ELF1	chr19:56271182-56271584	K562	blood:	n/a	chr19:56271419-56271432
18	MYC	chr19:56258306-56258412	MCF-7	breast:	n/a	n/a
19	MYC	chr19:56258308-56258414	MCF-7	breast:	n/a	n/a
20	PBX3	chr19:56277927-56278096	GM12878	blood:	n/a	n/a
21	POLR2A	chr19:56274116-56274147	A549	lung:	n/a	n/a
22	POLR2A	chr19:56259003-56259128	GM12878	blood:	n/a	n/a
23	POLR2A	chr19:56284139-56284358	A549	lung:	n/a	n/a
24	SPI1	chr19:56277792-56278107	GM12878	blood:	n/a	n/a
25	STAT3	chr19:56267962-56268162	MCF10A-Er-Src	breast:	n/a	chr19:56268133-56268141
26	STAT3	chr19:56276461-56276799	MCF10A-Er-Src	breast:	n/a	n/a
27	TBP	chr19:56270440-56270473	K562	blood:	n/a	n/a
28	TCF7L2	chr19:56265960-56266143	Hela-S3	cervix:	n/a	chr19:56265962-56265978 chr19:56265962-56265978 chr19:56265963-56265977 chr19:56265965-56265974

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:56274428-56274478	LNCaP	prostate:	n/a
2	chr19:56274428-56274478	LNCaP	prostate:	n/a
3	chr19:56269246-56269296	HMEC	breast:	n/a
4	chr19:56270729-56270779	AoSMC	blood vessel:	n/a
5	chr19:56270729-56270779	RPTEC	kidney:	n/a
6	chr19:56269246-56269296	LNCaP	prostate:	n/a
7	chr19:56269259-56269309	CMK	blood:	n/a
8	chr19:56269246-56269296	AG10803	skin:	n/a
9	chr19:56270498-56270548	HEEpiC	esophagus:	n/a
10	chr19:56274428-56274478	GM06990	blood:	n/a
11	chr19:56270729-56270779	Caco-2	colon:	n/a
12	chr19:56270729-56270779	BJ	skin:	n/a
13	chr19:56269246-56269296	IMR90	lung:	fetal
14	chr19:56269246-56269296	NT2-D1	testis:	n/a
15	chr19:56270729-56270779	Hepatocyte	liver:	n/a
16	chr19:56269246-56269296	HepG2	liver:	n/a
17	chr19:56269246-56269296	PANC-1	pancreas:	n/a
18	chr19:56269259-56269309	ProgFib	skin:	n/a
19	chr19:56270729-56270779	SK-N-SH	brain:	n/a
20	chr19:56274428-56274478	PFSK-1	brain:	n/a
21	chr19:56269259-56269309	SK-N-MC	brain:	n/a
22	chr19:56274428-56274478	HCT-116	colon:	n/a
23	chr19:56269246-56269296	NHDF-neo	bronchial:	n/a
24	chr19:56274428-56274478	HEK293	kidney:	embryo
25	chr19:56269246-56269296	HCPEpiC	choroid plexus:	n/a
26	chr19:56270498-56270548	HepG2	liver:	n/a
27	chr19:56270498-56270548	GM19239	blood:	n/a
28	chr19:56270729-56270779	ProgFib	skin:	n/a
29	chr19:56274428-56274478	Jurkat	blood:	n/a
30	chr19:56270729-56270779	AG04449	skin:	fetal
31	chr19:56269259-56269309	AG10803	skin:	n/a
32	chr19:56270498-56270548	NHBE	bronchial:	n/a
33	chr19:56274428-56274478	SK-N-SH	brain:	n/a
34	chr19:56274428-56274478	HNPCEpiC	eye:	n/a
35	chr19:56269246-56269296	Jurkat	blood:	n/a
36	chr19:56269259-56269309	LNCaP	prostate:	n/a
37	chr19:56270729-56270779	CMK	blood:	n/a
38	chr19:56269246-56269296	SKMC	muscle:	n/a
39	chr19:56274428-56274478	ovcar-3	ovarian:	n/a
40	chr19:56269259-56269309	HNPCEpiC	eye:	n/a
41	chr19:56274428-56274478	GM12891	blood:	n/a
42	chr19:56269259-56269309	HRCEpiC	kidney:	n/a
43	chr19:56269259-56269309	GM12878	blood:	n/a
44	chr19:56269259-56269309	SAEC	small airway:	n/a
45	chr19:56274428-56274478	HCM	heart:	n/a
46	chr19:56269259-56269309	SKMC	muscle:	n/a
47	chr19:56270729-56270779	HPAEpiC	pulmonary alveolar:	n/a
48	chr19:56274428-56274478	A549	lung:	n/a
49	chr19:56270498-56270548	RPTEC	kidney:	n/a
50	chr19:56274428-56274478	Caco-2	colon:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:56271991..56273573-chr19:56281048..56283702,2	K562	blood:
2	chr19:56271991..56273573-chr19:56281048..56283702,2	K562	blood:
3	chr19:56252523..56255492-chr19:56257324..56260762,3	K562	blood:

No data

Variant related genes	Relation type
RFPL4AL1	TF binding region
RFPL4AP1	TF binding region
RFPL4A	TF binding region
RFPL4AL1	CpG island
RFPL4AP1	CpG island
RFPL4A	CpG island

Extended variants
information (count: 755 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:755 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10416184	chr19:56264402-56264403	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs112914242	chr19:56264415-56264416	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs577447921	chr19:56264429-56264430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs534648424	chr19:56264459-56264460	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs557885908	chr19:56264461-56264462	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567697651	chr19:56264462-56264463	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs141201281	chr19:56264479-56264480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs10416393	chr19:56264491-56264492	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs574171460	chr19:56264505-56264506	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs12973665	chr19:56264521-56264522	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs111910789	chr19:56264535-56264536	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs147331682	chr19:56264546-56264547	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs545046862	chr19:56264623-56264624	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs565145396	chr19:56264651-56264652	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs139324971	chr19:56264653-56264654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs374025077	chr19:56264663-56264664	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs184924614	chr19:56264695-56264696	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs529138402	chr19:56264697-56264698	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs538627791	chr19:56264716-56264717	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs377731929	chr19:56264744-56264745	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs74419760	chr19:56264811-56264812	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs34837325	chr19:56264818-56264819	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs386389299	chr19:56264833-56264834	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs376868498	chr19:56264834-56264835	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs546125296	chr19:56264836-56264837	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs369229271	chr19:56264837-56264838	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs57710529	chr19:56264849-56264850	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs74179636	chr19:56264850-56264851	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs143044120	chr19:56264869-56264870	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs73933326	chr19:56264884-56264885	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs144677097	chr19:56264977-56264978	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs115133371	chr19:56264983-56264984	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs111482761	chr19:56265013-56265014	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs189778113	chr19:56265074-56265075	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs34047470	chr19:56265091-56265092	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs537119347	chr19:56265096-56265097	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs556806436	chr19:56265120-56265121	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs73055904	chr19:56265121-56265122	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs536488226	chr19:56265132-56265133	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs371149632	chr19:56265144-56265145	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs553248027	chr19:56265165-56265166	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs376628600	chr19:56265169-56265170	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs12460887	chr19:56265195-56265196	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533568271	chr19:56265203-56265204	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs182434812	chr19:56265204-56265205	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs148496136	chr19:56265205-56265206	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs554064513	chr19:56265206-56265207	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs558884325	chr19:56265217-56265218	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs575578302	chr19:56265277-56265278	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs142876336	chr19:56265373-56265374	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20459607	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Alzheimer''s disease	22166940	CNVD
Heart disease	21282601	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Glioblastoma multiforme	21922591	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:56264400-56265000	Enhancers	Liver	Liver
2	chr19:56264800-56265600	Enhancers	Rectal Mucosa Donor 31	rectum
3	chr19:56265000-56265400	Flanking Active TSS	Liver	Liver
4	chr19:56265000-56266000	Enhancers	Pancreas	Pancrea
5	chr19:56265400-56265600	Enhancers	Liver	Liver
6	chr19:56265400-56265800	Enhancers	Gastric	stomach
7	chr19:56265600-56265800	Flanking Active TSS	Liver	Liver
8	chr19:56265800-56268200	Weak transcription	Liver	Liver
9	chr19:56266000-56266800	Weak transcription	Pancreas	Pancrea
10	chr19:56266800-56267000	Enhancers	Pancreas	Pancrea
11	chr19:56267000-56268200	Weak transcription	Pancreas	Pancrea
12	chr19:56268000-56269800	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr19:56268200-56268400	ZNF genes & repeats	Liver	Liver
14	chr19:56268200-56268400	Enhancers	Pancreas	Pancrea
15	chr19:56268400-56272600	Weak transcription	Liver	Liver
16	chr19:56269800-56270200	Weak transcription	Primary monocytes fromperipheralblood	blood
17	chr19:56270200-56271800	Enhancers	Primary monocytes fromperipheralblood	blood
18	chr19:56272600-56272800	Active TSS	Liver	Liver
19	chr19:56277000-56279600	Enhancers	Primary monocytes fromperipheralblood	blood
20	chr19:56278000-56278200	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
21	chr19:56279600-56280000	Weak transcription	Primary monocytes fromperipheralblood	blood
22	chr19:56280000-56281800	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr19:56281200-56281800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links